Breastmilk and NICU surfaces are potential sources of fungi for infant mycobiomes.
Candida
/ isolation & purification
Cryptococcus neoformans
/ isolation & purification
DNA, Fungal
/ isolation & purification
Environmental Microbiology
Female
Fungi
/ cytology
Humans
Infant, Newborn
Intensive Care Units, Neonatal
Milk, Human
/ microbiology
Mycobiome
Saccharomyces cerevisiae
/ isolation & purification
Breastmilk
Fungi
Hospital surfaces
Mycobiome
Newborn intensive care
Journal
Fungal genetics and biology : FG & B
ISSN: 1096-0937
Titre abrégé: Fungal Genet Biol
Pays: United States
ID NLM: 9607601
Informations de publication
Date de publication:
07 2019
07 2019
Historique:
received:
30
11
2018
revised:
19
03
2019
accepted:
20
03
2019
pubmed:
25
3
2019
medline:
22
5
2020
entrez:
26
3
2019
Statut:
ppublish
Résumé
Surfaces within the neonatal intensive care unit (NICU), especially those handled frequently by hospital staff, provide sources of gut-colonizing bacteria for hospitalized infants, in addition to those acquired perinatally from maternal sources such as breastmilk. In comparison to bacteria, very little is known about potential sources of colonizing fungi in the NICU setting. Thus, the objective of this study was to characterize fungal communities (mycobiomes) of potential colonization sources for neonates hospitalized in a large university NICU. We hypothesized that the unit surfaces would contain different mycobiomes than those of human-associated (breastmilk) sources. We characterized mycobiomes of NICU surfaces of multiple individual patient care areas as well as those of breastmilk samples by sequencing the internal transcribed spacer region 2 (ITS2) of the fungal rDNA locus. We found that, across all samples, Candida and Saccharomyces species were the most prevalent taxa and had the greatest relative abundances. Breastmilk samples had significantly higher fungal alpha-diversities than NICU surface samples and fungal community compositions (beta diversities) differed significantly between the two sample types. Mycobiome compositions were predominantly driven by the relative abundances of three fungal taxa: Candida albicans, Candida parapsilosis, and Saccharomyces cerevisiae. In total, 21 individual fungal taxa showed significantly greater relative abundances in breastmilk as compared to NICU surfaces, with three being of particular interest to human health: Candida glabrata, Candida tropicalis, and Cryptococcus neoformans. Since no fungal DNA was detected when whole breastmilk was used as the DNA template, as opposed to breastmilk subjected to cell lysis during the DNA isolation procedure, our results indicate that DNA is from fungal cells and is not cell-free DNA. In summary, both NICU surfaces and human breastmilk harbor distinct fungal communities that could provide a source of fungi for the developing infant gut mycobiota. In particular, Candida and Saccharomyces species are abundant and prevalent for both of these potential sources that infants are exposed to.
Identifiants
pubmed: 30905830
pii: S1087-1845(18)30273-1
doi: 10.1016/j.fgb.2019.03.008
pmc: PMC6555646
mid: NIHMS1525841
pii:
doi:
Substances chimiques
DNA, Fungal
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
29-35Subventions
Organisme : NIAID NIH HHS
ID : R21 AI139730
Pays : United States
Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.
Références
Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):3047-52
pubmed: 21282636
Science. 2012 Jun 8;336(6086):1314-7
pubmed: 22674328
Nature. 2012 Aug 30;488(7413):621-6
pubmed: 22914093
Pediatr Clin North Am. 2013 Feb;60(1):49-74
pubmed: 23178060
Nucleic Acids Res. 2013 Apr 1;41(6):e67
pubmed: 23303777
J Clin Microbiol. 2013 Aug;51(8):2617-24
pubmed: 23740726
PLoS One. 2013 Nov 01;8(11):e78866
pubmed: 24223861
Microbiome. 2014 Jan 28;2(1):1
pubmed: 24468033
MBio. 2014 Jun 10;5(3):e01011-14
pubmed: 24917595
Front Microbiol. 2014 Jun 19;5:298
pubmed: 24995004
Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12522-7
pubmed: 25114261
Cell. 2014 Aug 14;158(4):705-721
pubmed: 25126780
Int J Obes (Lond). 2015 Apr;39(4):665-70
pubmed: 25298276
Adv Nutr. 2014 Nov 14;5(6):779-84
pubmed: 25398740
Trends Mol Med. 2015 Feb;21(2):109-17
pubmed: 25578246
PLoS One. 2015 Feb 23;10(2):e0116705
pubmed: 25706290
Sci Transl Med. 2015 Sep 30;7(307):307ra152
pubmed: 26424567
Stud Mycol. 2015 Jun;81:85-147
pubmed: 26955199
JAMA Pediatr. 2017 Jul 1;171(7):647-654
pubmed: 28492938
Front Microbiol. 2017 Jul 31;8:1432
pubmed: 28824566
Sci Rep. 2017 Oct 12;7(1):13016
pubmed: 29026146
mSphere. 2017 Oct 11;2(5):null
pubmed: 29034327
Cell Host Microbe. 2017 Dec 13;22(6):809-816.e4
pubmed: 29174402
Nat Commun. 2017 Nov 27;8(1):1814
pubmed: 29180750
mSystems. 2018 Mar 6;3(3):null
pubmed: 29546248
mSystems. 2018 Apr 24;3(3):null
pubmed: 29719872
Cell Host Microbe. 2018 Jul 11;24(1):133-145.e5
pubmed: 30001516
Cryobiology. 1977 Jun;14(3):251-72
pubmed: 330113
Science. 1970 May 22;168(3934):939-49
pubmed: 5462399